(Q46819446)

25 December 2017

title

A mathematical model for paroxetine antidepressant effect time course and its interaction with pindolol (English)

1 reference

25 December 2017

1 reference

Berangere Gruwez

1

1 reference

25 December 2017

Alain Dauphin

series ordinal

2

1 reference

25 December 2017

Michel Tod

series ordinal

3

1 reference

25 December 2017

publication date

1 December 2005

1 reference

25 December 2017

Journal of Pharmacokinetics and Pharmacodynamics

published in

1 reference

25 December 2017

volume

32

1 reference

25 December 2017

issue

5-6

1 reference

25 December 2017

page(s)

663-683

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s10928-005-0006-6

exact match

0 references

cites work

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10928-005-0006-6

Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine

21 January 2018

1 reference

12 December 2020

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

1 reference

12 December 2020

Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low.

1 reference

12 December 2020

Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique

1 reference

12 December 2020

The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteine

1 reference

12 December 2020

Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depressio

1 reference

12 December 2020

[Therapeutic action lag time and resistance to treatment]

1 reference

12 December 2020

Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration

1 reference

12 December 2020

Once-daily high-dose pindolol for SSRI-refractory depression

1 reference

12 December 2020

Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain

1 reference

12 December 2020

A review of the metabolism and pharmacokinetics of paroxetine in man.

1 reference

12 December 2020

Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans

1 reference

12 December 2020

Metabolic pathway of paroxetine in animals and man and the comparative pharmacological properties of its metabolites

1 reference

12 December 2020

A double-blind, randomized, fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression

1 reference

12 December 2020

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

1 reference

12 December 2020

Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression

1 reference

12 December 2020

The question of feedback at the somadendritic region and antidepressant drug action

1 reference

12 December 2020

Pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

12 December 2020

Clinical trial simulation of docetaxel in patients with cancer as a tool for dosage optimization

1 reference

12 December 2020

Physiologic indirect response models characterize diverse types of pharmacodynamic effects

1 reference

12 December 2020

Agonist and antagonist actions of (-)pindolol at recombinant, human serotonin1A (5-HT1A) receptors

1 reference

12 December 2020

(-)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis.

1 reference

12 December 2020

A comparison of paroxetine and placebo in depressed outpatients.

1 reference

12 December 2020

How long should pindolol be associated with paroxetine to improve the antidepressant response?

1 reference

12 December 2020

Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check

1 reference

12 December 2020

A set-point model with oscillatory behavior predicts the time course of 8-OH-DPAT-induced hypothermia

1 reference

12 December 2020

Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression

1 reference

12 December 2020

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

1 reference

12 December 2020

Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency

1 reference

12 December 2020

Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials

1 reference

12 December 2020

Clinical trial simulation in drug development

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors

1 reference

12 December 2020

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).

1 reference

12 December 2020

10.1007/S10928-005-0006-6

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017